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Abstract
The aim of our work is to use a new modality for visualization of intraocular tumors 
in three-dimensional space for planning of stereotactic radiosurgery procedure on 
linear accelerator. Malignant uveal melanoma is the most common malignant tumor 
of the inner eye structures in adults. Stereotactic radiosurgery on linear accelerator 
is the method of treatment that requires precise planning. However, in some cases, 
it is very difficult to imagine the structures based only on fusion of two-dimensional 
computed tomography (CT) and magnetic resonance imaging (MRI) scans. For the 
team of specialists planning the procedure, 3D printed models represent the way how 
to perceive the real shape of the tumor and its location considering the important 
structures of the eye globe. By using the open-source software for segmentation (3D 
Slicer), we created a virtual 3D model of the eye globe with a tumor that utilized tissue 
density information based on CT and/or MRI dataset. By creating and introducing a 
new imaging modality for tumor visualization, we provided real 3D model of the eye 
globe for the specialists that enabled them more effective planning of the stereotactic 
radiosurgery.
Keywords: fused deposition modeling, intraocular melanoma, stereotactic 
radiosurgery, 3D printer, 3D eye globe model
1. Introduction
Recent development of 3D printing enables to produce models of things, shapes, objects, and 
structures that before seemed more or less not possible to achieve. These technologies can 
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build a 3D object in almost any shape imaginable as defined in a computer-aided design 
(CAD) file. In a basic setup, the 3D printer first follows the instructions in the CAD file to 
build the foundation for the object, moving the head of the printer along the x-y plane. The 
printer then continues to follow the instructions, moving the head of the printer along the 
z-axis to build the object vertically layer by layer. It is important to note that two-dimensional 
(2D) radiographic images, such as x-rays, magnetic resonance imaging (MRI), or computed 
tomography (CT) scans, can be converted to digital 3D print files, allowing the creation of 
customized anatomical and medical structures [1].
Charles Hull invented 3D printing, which he called “stereolithography,” in the early 
1980s. Stereolithography uses the “.stl” file format to interpret the data in a CAD file, 
allowing specific instructions to be electronically communicated to the 3D printer. Along 
with dimensions, the data in the “.stl” file may also contain additional information for 
3D printer such as the color, texture, and thickness of the object. Hull later founded the 
company 3D Systems, which developed the first 3D printer, called a “stereolithography 
apparatus.” In 1988, 3D Systems introduced the first commercially available 3D printer, the 
SLA-250. Many other companies have since developed 3D printers for commercial applica-
tions. Hull’s study, as well as advances made by other researchers, had revolutionized 
manufacturing, and it was applied in many other fields, as well as in medicine research 
and practice [2].
Nowadays, many of 3D printing processes are available, and all of them offer advantages and 
disadvantages. The model of 3D printer selected for an appliance depends on the material 
types that should be used, and it depends on the required layers in the finished model they 
are supposed to be bonded. The used 3D printing technologies within medical applications 
are: selective laser sintering (SLS), thermal inkjet (TIJ) printing, and fused deposition model-
ing (FDM).
1.1. Selective laser sintering
An SLS printing technology uses as a substrate for printing new objects, a powdered material. 
The laser renders the shape of the object into a single layer of powder bonding the powder 
particles together. Then, a new layer of powder is laid down and the process repeats on and 
on, building layer by layer to form the object. Selective laser sintering can be used to create 
metal, plastic, and ceramic objects. The accuracy of the laser and the fineness of the powder 
material are limited by the degree of detail. This detail enables to create especially detailed 
and delicate structures, like the eye globe and its structures (lens, optic disc).
1.2. Thermal inkjet printing
Thermal inkjet printing is a “noncontact” technique that uses piezoelectric, thermal, or elec-
tromagnetic technology to deposit tiny droplets of ink or other materials that are used onto 
a substrate according to digital instructions. Heating of the head of the printer creates small 
air bubbles that collapse and create pressure pulses that eject ink droplets from nozzles in 
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volumes from 10 to 150 picoliters. Droplet size can vary by adjusting the applied temperature 
gradient, pulse frequency, and viscosity of the ink.
1.3. Fused deposition modeling
FDM printers are less expensive and more common than the SLS type. An FDM printer 
uses a head of the printer that is similar with an inkjet printer. However, instead of ink, as 
the printer’s head moves, beads of heated plastic are released and build the object in thin 
layers. This process is often repeated, allowing precise control of the location and amount 
of each deposit to shape each layer. Since the plastic is heated as it is extruded, it bonds 
or fuses with the layers below. As each layer of material cools, it hardens and creates the 
solid object as the layers build. Depending on the complexity and cost of an FDM printer, 
it may have features such as multiple heads of the printer. FDM printers can use a variety 
of plastics [3].
2. 3D printing in ophthalmology
3D printing was introduced to medicine at the beginning of this century, when the technol-
ogy was first used to create dental implants and individualized prosthetics. Since then, the 
medical applications for 3D printing technology have progressed significantly. The first pub-
lished reviews describe the importance, utilization and results of 3D printing when applied 
in the field of orthopedic surgery, cardiovascular surgery, and tissue engineering, as well as 
in pharmaceutical development (new dosage forms, delivery of medicines, etc.). The cur-
rent medical application of 3D printing technology is classified into several groups, such as 
prosthetics, implantation, and precise anatomical models; production of tissues and organs; 
and research in pharmaceutical industry on drug discovery, design of dispensers, and drug 
dosage forms [4].
2.1. 3D printing for eyewear and medical devices
3D printing technology has progressed to the point when companies print custom-made 
eyewear with their own design and on demand. The market for customization of eyewear 
has been made possible by a rapid prototyping. 3D printing enables and simplifies on 
demand production of medical devices in plastic or metallic form, and in the future, may 
represent the best way to produce artificial lenses, glaucoma valves and other personalized 
implants.
2.2. For education and clinical practice
3D printed models are already used in institutions for medical education—due to their 
accurate visualization are being used to introduce surgical techniques to trainees, young 
doctors or students before they start to treat patients. Surgical simulations using 3D models 
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allow students to practice in a safe environment, until they can perform the techniques at 
the expected level. Hypothesis that these models can shorten the learning curve, standardize 
training and assessment, became true. The results show that trainers using 3D printed models 
have done a lot to finish their tasks better and have a better learning experience than those 
who used only digital models or textbooks. This suggests that using 3D models enhances 
the understanding of anatomical structures, their collocations, and their relationships. With 
the advancement of 3D printing technology, the 3D print models can be made available to 
improve the training of young ophthalmologists in a simulated operating theater environ-
ment, thus improving the training experience.
2.3. For printing of live cells, tissues, and organs
The development of 3D bioprinting technology, including the printing of living cells, differ-
ent tissues, and even organs, is now becoming an important and expanding field of medical 
research. From 2012, this technology has been studied in academic circles and by biotech-
nology corporations (e.g., Organovo Co., San Diego, CA, USA) for possible use in tissue 
engineering applications, where tissues and organs are created by using 3D inkjet printing 
technology. The technology process is based on placing living cells onto a gel medium or 
sugar matrix and layer-by-layer predefined 3D structures are formed. In this way, blood 
vessels, bones, ears and other structures can be printed. Using 3D bioprinting technology 
in 2014, researchers successfully implemented a 3D skull component into a patient, with no 
adverse effects. This new technology represents an extension of the treatment options for 
creating and adapting personalized implants to the patient. The use of three-dimensional 
bioprinting in ophthalmology is, however, still limited, but for the generation of ocular tis-
sues (e.g., conjunctiva, sclera, and corneas), the use of 3D bioprinting technology in the future 
has a great potential.
2.4. For surgical planning
In the first place, the ophthalmologist must comprehend complicated anatomical structures 
of the eye globe and orbit and their connection with the suspected lesion. Structural rela-
tionships observed and defined between orbital structures, muscles, vessels, and nerves can 
be difficult to assess fully during the planning of the orbital surgery, based solely on the 2D 
scans obtained. The small surgical access field for eye globe (diameter 24 mm) also means 
that any mistake in navigating in this structures and complicated anatomy can have poten-
tially devastating consequences for the patient—postradiation complications. Experience 
proves that, for both practical and educational purposes, the creation of an anatomically 
personalized organ models by using 3D printing technology is very useful. This technology 
allows a full appreciation of anatomical relationships and collocation between tumors or 
lesions and other complicated surrounding, but healthy structures. Advances in 3D print-
ing technology enable the real prototyping of various anatomical structures and allow 
accurate representation of the patient’s current state. In surgical or irradiation planning 
schemes in human medicine, it will be an invaluable aid to have this real 3D organ models. 
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It will provide a better possibility and learning experience for the doctors, physicists and 
surgeons [4].
We introduced the 3D printing technology into a process of planning stereotactic radiosur-
gery (SRS) in patients as a treatment of intraocular tumor—uveal melanoma [5, 6].
3. Intraocular melanoma
3.1. Definition
Intraocular melanoma is a quite rare type of cancer and is a disease in which tumor cells are 
formed in the part of the eye globe called the uvea (iris, ciliary body and choroid). Intermediate 
layer of the eye globe (uvea) contains melanocytes. Process of melanogenesis leads to produce 
melanin (can be found also in hair and in skin).
There are some cases in which doctors have detected intraocular melanoma during a rou-
tine eye globe examination. The chance of recovery depends on factors such as the size and 
cell type of the tumor. In support of classification, the staging system tumor node metastasis 
(TNM) is used for standardization of the tumors so the care teams can summarize information 
about how a tumor has spread. The information about the TNM classification is combined by 
a process called stage grouping. For example, intraocular melanoma grade T4 (due to clas-
sification) spreads to the orbit and extraocular tissues.
Uveal melanoma is relatively rare type of cancer, but the most common and most aggressive 
type of intraocular tumor in adults. The incidence of intraocular tumors varies from 0.2 to 1.0. 
Uveal melanoma mostly occurs in middle-aged people [7, 8].
3.2. Signs and symptoms
Most people with intraocular melanoma experience no symptoms of the disease in its early 
stages.
As the disease progresses, the following signs and symptoms can be seen:
• A growing dark spot on the iris.
• Change in the size or shape of the pupil.
• Problems with vision (blurry vision or sudden loss of vision).
• Floaters (spots or squiggles drifting in the field of vision) or flashes of light.
• Visual field loss (losing part of your field of sight).
• Increased intraocular pressure (secondary glaucoma).
• Change in the way the eye globe moves within the socket.
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Only in cases when there is a massive spread outside of the eye globe, there may be pain. If 
someone has any of the symptoms above, it is important to visit a doctor immediately so the 
cause can be found and treated.
3.3. Localization of uveal melanoma
The localization of uveal melanoma is defined based on the area where the tumor is found 
in the eye globe and optionally based on the size of the tumor. The main localizations of the 
intraocular melanoma include the following tumors due to anatomical localization:
• Melanoma of the iris.
• Ciliary body melanoma.
• Choroidal melanoma (Figure 1).
In certain cases, intraocular melanoma can be complicated by extraocular extension. The most 
frequent metastases of uveal melanoma are in the liver.
3.4. Diagnostic methods
Slit lamp examination, ophthalmoscopy and fund us photo documentation are basic examina-
tion methods.
Melanomas from choroidea can vary from dark pigmented to amelanotic, some even partially 
pigmented. Small choroidal melanomas are characteristic with a typical shape, where the mass 
under the retinal pigment epithelium is nodular, dome-shaped and well-defined. During the 
growth of choroidal melanoma, more irregular configurations and shapes, such as bilobular, 
multilobular or spongy are observed. Diffuse choroidal melanoma, whose lateral growth in cho-
roids with minimal elevation is a characteristic feature, it is more difficult to make a diagnosis. 
In many cases, the diffuse choroidal melanoma causes significant exudative retinal detachment.
If the tumor is lightly pigmented, then its abnormal vascularization can usually be detected 
by ophthalmoscope. Excessive choroidal melanomas usually cause changes in the epithelial 
Figure 1. Enucleated eye globe with intraocular tumor—arrows shows the tumor mass (choroidal melanoma).
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pigment of the retina (e.g., drusen), atrophy patches and orange color change. These changes 
can occur not only in malignant but also in benign lesions. Choroidal melanoma may remain 
undetected under a great exudative retinal detachment or subretinal or vitreous bleeding.
A rare occurrence of advanced choroidal melanoma results in a painful blind eye globe with 
cataracts and proptosis, resulting from tumor transscleral orbital enlargement. In anterior 
choroidal melanomas, sentinel vessels (dilated episcleral vessels visible through the conjunc-
tiva) that nourish the metabolically active tumor may occur. Transscleral growing of the ante-
rior choroidal melanoma (predominantly via the emission channels) can be identified during 
the examination as a small subconjunctival area of abnormal hyperpigmentation.
3.4.1. Ultrasonography
In the case of eye globe tumors having a diameter greater than 2–3 mm, A-scan ultrasonog-
raphy is suitable for diagnosis. The choroidal melanoma scan depicts a characteristic initial 
prominent spike, followed by low to moderate internal reflection with decreasing amplitude 
and significant echo. Vascular pulses can be seen as fine oscillations of the internal spiking 
model in the tumor area. Standard ultrasonography, currently used, has a diagnostic accuracy 
of more than 95%. Performing sequential A-scans with accurate dimensional measurements 
is a recommended complementary method after uncertain outcome of primary diagnostics.
B-scan ophthalmological ultrasonography is performed routinely for the evaluation of any sus-
picious mass located in the posterior segment, especially in the patients with media opacity. For 
the diagnosis of choroidal melanomas, this method helps to determine not only the correct diag-
nosis, but also to evaluate possible extraocular enlargement, to estimate the size of the tumor 
after periodic recurrent observations, and to appropriately schedule a therapeutic intervention.
Intraocular melanomas have several characteristics as follows:
• An acoustic quiet zone at the base of the tumor called acoustic hollowing.
• Low-to-medium reflectivity.
• Internal vascularity.
• Excavation of underlying uveal tissue.
• Shadowing of subjacent soft tissues.
Ultrasound biomicroscopy (UBM) uses high-frequency waves. This method has excellent 
resolution and is therefore suitable for the diagnosis of anterior ocular abnormalities. It has 
ability to distinguish very frontal choroidal melanomas from those that originate from the 
ciliary body. Moreover, it can help define the frontal plane of the tumor or help to assess angle 
closure glaucoma.
3.4.2. Angiography and radiography
In case of doubts, diagnostics of choroidal melanoma can be confirmed by fluorescein angi-
ography or indocyanine green angiography, mostly in cases, when the lesions do not show 
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pathogenic symptoms. Fluorescein angiographic changes, which can be observed in small cho-
roidal melanomas, may be similar to some choroidal nevi. Such changes range from normal 
angiography findings to hypofluorescence developed secondary to blockage of the background 
fluorescence. In larger melanomas, a patchy pattern of early hyper- and hypofluorescence may 
occur, which can be followed by late intense staining. In some cases, choroidal melanomas can 
develop their own internal vascularization so that appear on the angiogram. Simultaneous 
fluorescence of the choroidal and retinal circulation in the tumor is an angiographic feature, 
called the “double circulation model.” Its occurrence differs from choroidal melanomas.
3.4.3. Computed tomography
Computer tomography (CT) imaging method is more expensive and less sensitive compared 
to ultrasonography. However, it is used for scanning of the eye globe and orbit due to its abil-
ity to visualize extraocular tumor growth and to help distinguish between choroid or retinal 
detachment and solid tumor.
Prior to this examination, application of intravenous injection of the contrast agent is needed. As 
a result, contrast will cause enhancement of choroidal melanoma, whereas in case of exudation 
will not.
3.4.4. Magnetic resonance imaging
Magnetic resonance imaging (MRI), also used for scanning the eye globe and orbit, is even 
more expensive than CT scanning and less sensitive than ultrasound. However, MRI uses sur-
face coil imaging and gadolinium as a contrast material for improving its resolution. Within 
the MRI, high-density lesions represent T1-stage pigmented melanomas, and low density can 
exhibit pigmented melanoma at T2 stage. In many cases, MRI is used to determine the extra-
scleral melanoma enlargement or to distinguish surrounding fluid from the tumor.
3.4.5. Biopsy and genetic analysis
Practice usually does not require the use of a fine needle biopsy and an incisional biopsy. 
However, these additional examination methods may be useful in differential diagnosis. They 
are used to distinguish amelanotic melanomas from metastatic tumors and as complemen-
tary tests, if the results of other tests are ambiguous. It is possible to achieve more than 95% 
accuracy in tumors larger than 3 mm using both types of biopsy. Comparing both methods, 
incisional biopsy is more invasive and comes with higher complications rate, but has lower 
rate of falsely positive or negative results. Intralesional or perilesional hemorrhage are the 
most common complications, a fine needle biopsy is not connected with higher risk of spread-
ing cancer cells in the case of choroidal melanoma.
Following biopsy, the prompt treatment is indicated with an aim to prevent extrascleral extension.
Nowadays, genetic analysis and karyotyping of biopsy samples are becoming more important. 
Various studies have documented that Chromosome 3 monosomy in the choroidal tumor is 
associated with a significantly higher risk of developing metastatic process. Nowadays, sadly, 
there is still no effective treatment for metastatic disease available.
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3.5. Treatment opportunities
The important prognostic indicators they initiate the following therapy for posterior uveal 
melanoma are the age and the volume (size) of the tumor. Many studies are documenting 
that over 50% of patients with uveal melanoma die because of direct or indirect reasons (e.g., 
metastasis) within 15 years after the therapy, although radical surgery (enucleation) or other 
therapeutical methods are used.
In turn, modern diagnostic tools, they include ophthalmological examination, CT, and MRI 
brought most vital advances in the ability of primary uveal melanoma diagnosis. The diagnostic 
methods have radically improved in the last decades, and different types of radio surgery (exter-
nal beam, charged particle or brachytherapy) have become the preferred treatment in significant 
number of patients with uveal melanoma. One of the main reasons for the development of alter-
native therapies is the objective of promoting survival and maintaining vision in patients who 
have experienced uveal melanoma. Among other things, many types of radiation are used in 
today’s treatment of posterior uveal melanoma. One of the representatives of the “conservative” 
approach is stereotactic radiosurgery (SRS) with the usage of a linear accelerator.
In addition to SRS, the gamma-knife radiosurgery method is used. Both methods provide 
good local control with survival rates comparable to other treatments. SRS of extracerebral 
lesions, such as uveal melanoma, has been invented about 20 years ago. An alternative treat-
ment that has been proven to treat middle and large posterior choroidal melanoma is the 
SRS method. Another method is the plaque radiotherapy, when the eye globe salvation is 
achieved. It is used especially in cases of tumor location outside the optical disc or the macula. 
The positive consequence for the patient is the useful vision that can be retained after treat-
ment. Linear accelerator therapy with a single fraction of the intraocular tumor is considered 
to be a relatively unusual approach to the treatment of uveal melanoma. For treatment plan-
ning coordinates is used an image fusion of a contrast-enhanced MRI and CT. When using a 
collimation system in an operation, it is important to achieve spatial accuracy when adminis-
tering one fraction [9–11].
4. Stereotactic radiosurgery for intraocular tumors
Stereotactic radiosurgery was initially developed in 1949 by Lars Leksell, the Swedish neuro-
surgeon, who treated small targets of tumors located in the brain. It was a new step in radio-
therapy methods. Nowadays, the stereotactic radiosurgery (or external beam irradiation with 
protons or helium ions) is a regularly used option in the treatment of mainly medium-sized 
choroidal melanomas. In many cases, it has been applied for larger tumors. Eye globe and 
orbit scanning by CT or MRI is necessary for verifying of extraocular extension. It is necessary 
to use these techniques to differentiate between choroidal tumor and primary versus second-
ary retinal detachment. Every patient with a medium-sized melanoma is sent to chest X-ray, 
liver ultrasound, and general examination but also to PET/CT to detect possible metastases.
Methods like MRI, CT and also digital subtraction angiography (DSA) are included in imag-
ing equipment. Structures of the eye globe and lesions are defined, visualized and localized. 
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Software for target verification, which is used in conjunction with stereotactic frame system 
and imaging (CT, MRI) modalities, is used to determine the coordinates of the lesion (tumor) 
target into the stereotactic frame reference system.
The radiosurgical treatment is calculated by physicist by planning system for treatment (TPS) 
with the 3-D dose distribution. The result is superimposed onto the certain patient’s anatomi-
cal status to get an appropriate radiation dose for tumor and also for risk structures (optic 
nerve, lens, chism, etc.) and radiosurgical procedure [12–14].
5. 3D printed models of the intraocular melanoma for planning of 
stereotactic radiosurgery treatment
Stereotactic radiosurgery (SRS) is a technically challenging therapeutic irradiating method. 
It complements or supplies (replaces) classic surgical intervention. It is used for single high-
therapeutic irradiation dosage to an exact specified volume, while risk organs and structures 
are contemporary protected. A prerequisite for this method is a special software and hard-
ware equipment of workstation and professional experiences of specialists of different fields 
(neurosurgeon trained in stereotactic radiosurgery, radiation oncologist, ophthalmologist, 
radiologist, clinical physicist and registered nurse trained for radiosurgery).
The surgical operation involves the selection and preparation of the patient prior to surgery inter-
vention, which consists from processing of health and imaging documentation of the patient. 
It is necessary to analyze the patient’s disease and the patient’s indication by the Indicating 
Commission (BTB). The Commission decides about the indication in which the members are 
neurosurgeons trained in radiosurgery, radiation oncologists, ophthalmologists, radiologists 
and clinical physicists. The progress committee decides on the basis of a recommendation on 
the appropriateness of an eye globe oncological surgery, the listed group of experts will evalu-
ate the suitability of classical surgery, stereotactic radiosurgery operations, fractionated stereo-
tactic radiosurgery, intensity modulated radiotherapy (IMRT) or three-dimensional comfort 
radiotherapy (3D-CRT).
Patients indicated for stereotactic radiosurgical intervention are hospitalized for inpatient 
care. This is a short-term hospitalization, most often lasts 3 days. The patient admission 
involves interview with the patient with detailed information about the course of operation, 
performance benefits as well as acquaintance with potential acute and late postoperative com-
plications (adverse effects). The patient subscribes the informed consent.
Patient’s admission in hospital bed department (clinical care) is carried out 2 days before the 
surgery. A detailed clinical examination will be done, brought documentation is studied, the 
missing examinations are completed and a preoperative pharmacotherapy treatment in hos-
pital bed department is placed on. Findings, surgery and documentation will be inserted into 
the hospital information system. The day before the stereotactic radiosurgery (SRS) will be 
initiated the patient’s pharmacotherapy—premedication. Within the preoperative premedi-
cation, the patient is receiving the antiedematotic therapy, which intensity depends on the 
size, location of the lesion and the presence of edema. The presented therapy is continued in 
the day of surgery and the following day.
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Each patient’s record includes the tumor size, tumor volume, the maximum height of the 
tumor, age and gender, the presence and the extent of secondary retinal detachment, and 
the possible signs of extrascleral extension. The very important step of SRS is tumor volume 
calculation in each patient directly by results of CT and MRI examination. It is the basic step 
involved to the stereotactic planning scheme.
Immobilization of the affected eye globe for stereotactic irradiation is achieved by mechanical 
fixation of the sutures to the Leibinger stereotactic frame. Vicryl sutures from four extraocular 
muscles (m. rect. sup., m. rect. inf, m. medialis and m. temp.) are placed through the con-
junctiva and the lids. The stereotactic frame is fixed to the head, and the sutures are tied to 
the stereotactic frame. The day after stereotactic irradiation is the patient examined by an 
ophthalmologist (the slit lamp examination, ophthalmoscopy, and intraocular pressure mea-
suring) and is released for home treatment, he gets antibiotic and corticosteroid eye drops.
In software for data segmentation (3D Slicer, freeware version 4.5.0+), virtual 3D models of 
the eye globe were created. Imported data set came from CT (computer tomography) with 
accuracy 1 mm scan thickness. Visualized and created model has basic anatomical structures 
like globe, corneal segment, lens, optic nerve and tumor mass inside the created 3D model of 
eye globe. Extraocular muscles and vitreous body are not included in the model. Eye globe 
anatomical structures—lens and optic nerve—are very important for orientation. They are 
necessary visible points at the small printed 3D model because the model itself has the same 
size as the normal human eye globe—from anterior to posterior part is 24 mm. Virtual 3D 
model of the eye globe is then sliced. Additional support is calculated. The next step can 
be model preparing for printing in 3D printing slicing software Simplify3D. After creating 
and refining our models, for process of 3D printing, we used fused deposition modeling 
(FDM) technology. The 3D models in our study are printed on ZYYX 3D Printer by Magicfirm 
LLC using one extruder heated to 215–230°C. Chosen material is polylactic acid (PLA) with 
low deformability during rapid temperature changes and contributing high accuracy of the 
model. One layer of the model thickness of in vertical line is 100 μm. This provided an ideal 
proportion of a ratio between accuracy and velocity of a printing process. Estimated time of 
printing process in 3D printer is usually from 15 to 30 min per one model (Figures 2 and 3).
Figure 2. 3D printed model of the eye globe with intraocular tumor—arrow shows the tumor mass (melanoma).
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Figure 3. MRI scan of eye globe with uveal melanoma (choroidal melanoma stage T1b)—red color, lens—green color, 
optic nerve—yellow color.
Stereotactic one-day session therapy of intraocular uveal melanoma, based on CT and MRI 
images, is a precise treatment option and safe. The results of the treatment were summarized 
in the study and demonstrated that the local control was excellent. Among other results, they 
have further shown that in patients with an unfavorable tumor size and localization near 
critical structures such as the optic nerve, lens and macula, visual acuity has been reduced. 
In the patient’s follow-up after 6 months, visual acuity was evaluated. The study included 
a group of 77 patients in whom 85.5% of patients had a visual acuity of 0.1 or higher before 
radiotherapy. In the cases with intraocular uveal melanoma, these patients may be recom-
mended to undergo LINAC-based one-day session stereotactic irradiation, especially in the 
cases of medium-sized uveal melanomas. Important advantage of this treatment method is 
preserving of the eye globe [5, 6].
6. Discussion
In the treatment of the uveal melanoma patients, stereotactic irradiation has been used over 
20 years. Over time, the therapeutic single dose decreased and stabilized at 35.0 Gy. In the 
studies, this reduction did not lead to tumor control reduction. The studies also documented 
that hypofractionated treatment is beneficial. This treatment uses a very large fraction to sta-
bilize the intraocular uveal melanoma cell lines.
In the last years, additional interest in fractionated stereotactic radiotherapy (SRT) was 
obtained. Feasible fractionation advantage is used by Linear accelerators (LINAC). Nowadays, 
therapeutic schemes for hypofractionated therapy for five fractions with total doses from 50.0 
to 70.0 Gy are employed by most LINAC studies. Different studies report local tumor with 
control rates more than 90% by the efficacy of SRT in uveal melanoma treatment. In treatment 
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of melanoma close to the optic disc, juxtapapillary choroidal melanoma, this stereotactic 
radiotherapy offers another non-invasive alternative to radical surgery—enucleation—or to 
brachytherapy treatment with high tumor control rate [9, 15].
The gamma knife radiosurgery and SRS are evaluated as the alternative in patients with large 
tumors (stage T3) which are too large for conventional brachytherapy. Studies confirm with their 
results that treatment with SRS may also be recommended in specific cases of uveal melanoma 
[16, 17].
Interesting is the comparison with other forms of radiotherapy. Typical side effects of radiation 
from SRT include: radiation retinopathy, cataract development, secondary neovascular glau-
coma, and opticopathy. The result may be loss of visual acuity. In the worst cases, secondary 
enucleation is necessary. However, even with these risks, SRS and SRT are among the most 
effective treatments for uveal melanoma. The SRS method belongs to one of the new methods; 
therefore, it is needed to record and compare results with other methods by a multicenter stud-
ies. Treatment of uveal melanoma using a combination of stereotactic photon therapy and CT 
and MRI scans is considered very safe and accurate and guarantees excellent local control. 
A reduction in visual acuity was observed in a large number of patients. This condition was 
a result of the unfavorable size and position of the tumor near critical structures, such as the 
optic nerve and the macula. Obtained patient observations confirmed that stereotactic irradia-
tion for uveal melanoma using LINAC is feasible and well tolerated. This treatment preserves 
the patient’s eye globe and is offered in the case of moderate or unfavorably localized uveal 
melanomas [5].
Optical neuropathy may rarely occur after radiosurgical treatment of lesions that are 
located near visual pathways. A highly effective method in these cases for the treatment of 
small and moderate uveal melanomas is a one-step LINAC-based SRS with a single dose of 
35.0 Gy. This treatment involves the use of a mechanical immobilization system with four 
stitches [18].
3D printing has gained its new role in ophthalmology by confirming and demonstrating the 
real shape and size of tumors by creation of accurate 3D models. With current advances of 
precise modeling process, material to build the 3D models can be printed at 600 μm resolution.
This approach is already in use within the other fields of ophthalmological surgery. An exam-
ple is the use in cataract surgery—development of Cana’s Ring (CR) and a special expansion 
device for 3D pupils [19].
Another example of the practical use of 3D printing in ophthalmology is the eye fundus 
examination. The correct collocation of the patient, the smartphone and the Volk spherical 
lens is extremely important. To secure the correct position, a 3D printed adapter from plastic 
was created to connect the lens with the smartphone together [20].
Different studies evaluated the efficacy of stereotactic radiosurgery as a treatment modality 
for uveal melanoma. Tumor control rates 5 and 10 years after therapy were over 90% in several 
studies. Results of these studies did not show a significant difference between radiogenic side 
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effects of SRS and other forms of radiotherapy. Majority of visual acuity decline and necessity 
of secondary enucleation are neovascular glaucoma. Radiation therapy of stereotactic photon 
beams for the treatment of intraocular melanoma is considered effective nowadays. However, 
it is still recommended for future studies and follow-up actions to focus on finding optimal 
treatment modalities [21].
3D printed model of eye globe with tumorous mass is due to our experience helpful during 
the stereotactic planning process. Planning of stereotactic radiosurgery is based on fusion of 
CT and MRI data. Understanding of the collocation of all the structures of the eye globe with 
critical structures inside, such as lens, optic disc and the tumor size and its location, is a basic 
condition for the planning software.
By introducing a new 3D modality for visualization of the eye globe with the tumor, we 
provided real model of the eye globe for the specialists, which enabled them increase effec-
tiveness of the planning process during the stereotactic radiosurgery. Virtual 3D model can 
be seen on computer only, but real printed 3D model of the eye globe held by the physician 
and physicist in their hands gives them a better perspective of the real situation inside the 
eye globe, like the size, the distance of the tumor to critical structures, the lens, optic disc and 
optic nerve [5].
7. Conclusions
The number of patients in our study with reduced visual acuity will probably increase in the 
future. Created model was used for comparison with pictures of the eye globe after enucle-
ation due to secondary complications (amotio retinae). In future, we plan to make a collection 
of interesting models of rare cases for purposes of education.
Current possibilities of creating the real-sized or even also enlarged 3D models of the 
affected eye globe help ophthalmologists and other specialists to comprehend and visual-
ize the size and localization of the tumor, has been rather difficult before, solely with the 
2D radiographic imaging. The 3D model of an eye globe with an intraocular tumor has 
an important role during the process of preparing a stereotactic radiosurgery planning 
scheme. This is a step forward for the team of specialists responsible for management and 
treatment of a patient with malignant melanoma. Implementation of a 3D model in the 
process of individualized irradiation planning of stereotactic surgery has a great potential 
for the future.
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